The Glucagon–Miniglucagon Interplay
- 1 July 2006
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1070 (1) , 161-166
Abstract
Miniglucagon (glucagon 19–29) is the ultimate processing product of proglucagon, present in the glucagon‐secreting granules of the α cells, at a close vicinity of the insulin‐secreting β cells. Co‐released with glucagon and thanks to its original mode of action and its huge potency, it suppresses, inside the islet of Langerhans, the detrimental effect of glucagon on insulin secretion, while it leaves untouched the beneficial effect of glucagon on glucose competence of the β cell. At the periphery, miniglucagon is processed at the surface of glucagon‐ and insulin‐sensitive cells from circulating glucagon. At that level, it acts via a cellular pathway which uses initial molecular steps distinct from that of insulin which, when impaired, are involved in insulin resistence. This bypass allows miniglucagon to act as an insulin‐like component, a characteristic which makes this peptide of particular interest from a pathophysiological and pharmacological point of views in understanding and treating metabolic diseases, such as the type 2 diabetes.Keywords
This publication has 13 references indexed in Scilit:
- Extracellularly Regulated Kinases 1/2 (p44/42 Mitogen-Activated Protein Kinases) Phosphorylate Synapsin I and Regulate Insulin Secretion in the MIN6 β-Cell Line and Islets of LangerhansEndocrinology, 2005
- Miniglucagon (MG)-Generating Endopeptidase, which Processes Glucagon into MG, Is Composed of N-Arginine Dibasic Convertase and Aminopeptidase BEndocrinology, 2005
- Glucagon Promotes cAMP-response Element-binding Protein Phosphorylation via Activation of ERK1/2 in MIN6 Cell Line and Isolated Islets of LangerhansJournal of Biological Chemistry, 2004
- Assessment of the Role of Interstitial Glucagon in the Acute Glucose Secretory Responsiveness of In Situ Pancreatic β-CellsDiabetes, 2002
- Miniglucagon (Glucagon 19-29)Diabetes, 2002
- Glucagon receptors on human islet cells contribute to glucose competence of insulin releaseDiabetologia, 2000
- Miniglucagon (Glucagon 19–29), a Potent and Efficient Inhibitor of Secretagogue-induced Insulin Release through a Ca2+PathwayJournal of Biological Chemistry, 1999
- Evidence that glucagon stimulates insulin secretion through its own receptor in ratsDiabetologia, 1995
- A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagonNature, 1987
- A morphological basis for intercellular communication between alpha- and beta-cells in the endocrine pancreas.Journal of Clinical Investigation, 1975